EUVIMEDEUVIMED entdecken
EditorialKommentar

More is better? Hypertonic saline dose and response for cystic fibrosis: efficacy, tolerability and implications for clinical practice

Scott H Donaldson iD

European Respiratory Journal · 2023

DOI: 10.1183/13993003.00865-2023 ↗

Kurz gefasst

Editorial in der Zeitschrift European Respiratory Journal, 2023. Verfasst von Scott H Donaldson. Beteiligte Einrichtung: University of North Carolina at Chapel Hill School of Medicine, Division of Pulmonary and Critical Care Medicine, Chapel Hill, NC, USA scott_donaldso…. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tweetable abstract Higher concentrations of hypertonic saline provide greater protection against pulmonary exacerbation and respiratory symptom improvement in people with cystic fibrosis, and are generally well tolerated when delivered with rapid nebuliser systemshttps://bit.ly/3WPkFsy

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisHumansSaline Solution, HypertonicMucociliary Clearance

Substanzen

Saline Solution, Hypertonic

Autor:innen und Institutionen

  • University of North Carolina at Chapel Hill School of Medicine, Division of Pulmonary and Critical Care Medicine, Chapel Hill, NC, USA scott_donaldson@med.unc.edu.

ORCID-Profile: Scott H Donaldson

Zitieren

APA

Donaldson, S. H. (2023). More is better? Hypertonic saline dose and response for cystic fibrosis: efficacy, tolerability and implications for clinical practice. European Respiratory Journal. https://doi.org/10.1183/13993003.00865-2023

Vancouver

Donaldson SH. More is better? Hypertonic saline dose and response for cystic fibrosis: efficacy, tolerability and implications for clinical practice. European Respiratory Journal. 2023. doi:10.1183/13993003.00865-2023

BibTeX
@article{Donaldson2023,
  author = {Donaldson, Scott H},
  title = {More is better? Hypertonic saline dose and response for cystic fibrosis: efficacy, tolerability and implications for clinical practice},
  journal = {European Respiratory Journal},
  year = {2023},
  doi = {10.1183/13993003.00865-2023}
}
Kostenlos starten →